UNSPSC 85893954: High dose rate (hdr) brachytherapy of ovary using palladium 103 (pd-103)

This classification denotes the group of activities that yields a radiation therapy intervention or procedure of high dose rate (hdr) brachytherapy of ovary using palladium 103 (pd-103). This intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code DU109BZ

UNSPSC 85893954 High dose rate brachytherapy of ovary using palladium 103, a Commodity code, shows a significant mismatch between its nominal scope and recent state and local procurement activity. The code's technical description specifies a highly specialized oncology procedure — radiation therapy involving internal application of radioactive palladium isotopes for ovarian cancer treatment — yet the single recent opportunity posted under this code is entirely unrelated to that clinical service.

The County of Santa Clara Health System's July 2026 RFQ (RFSQHHSFY270052), due October 7, 2026, solicits temporary health professional staffing services across thirteen ancillary clinical categories including audiology, diagnostic imaging, gastroenterology, orthopedic services, patient transport, sterile processing, and surgical nursing support — none of which align with brachytherapy service delivery or oncology radiation therapy. This appears to reflect a classification error in the source opportunity rather than legitimate procurement activity under the code's intended scope. No additional state and local opportunities under this code are documented in the source. The mismatch between the code's narrow clinical specification and the Santa Clara Health System's broad ancillary staffing solicitation suggests that either the opportunity was miscoded or that state and local procurement volume under UNSPSC 85893954 for actual brachytherapy services is not currently visible in recent posted notices.